MATRix/IELSG43
MATRix/IELSG43: Phase III Trial of High-Dose Chemotherapy + ASCT vs Nonmyeloablative Chemoimmunotherapy as Consolidation for Primary CNS Lymphoma

Released: December 17, 2022

Expiration: December 16, 2023

Activity

Progress
1
Course Completed